-->
Strides Pharma Soars 10% On Development Of Antivirals For Covid-19

Strides Pharma Soars 10% On Development Of Antivirals For Covid-19

Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.

from NDTV Profit - Latest https://ift.tt/2SiYQ4w

0 Response to "Strides Pharma Soars 10% On Development Of Antivirals For Covid-19"

Post a Comment

Ads on article

Advertise in articles 1

advertising articles 2

Advertise under the article